The Cobra Effect and Cannabis
For much of the recreational cannabis industry, one number has become the shorthand for quality: THC percentage. Walk into a dispensary and consumers are routinely presented with flower labeled at 30% THC or higher.
Producers know those numbers influence purchasing decisions. Retail buyers know high-THC products are easier to sell. Cultivators, breeders, testing laboratories, and brands consequently operate in a market where a few percentage points of THC can have a massive effect on the perceived value of a crop.
The result is a textbook example of the Cobra Effect: an incentive designed to produce one desirable outcome ends up encouraging behavior that undermines the original goal.
The term "Cobra Effect" comes from a famous story about British colonial rule in India. According to the story, officials concerned about venomous cobras offered residents a bounty for every dead cobra they delivered. Initially, the incentive appeared straightforward: pay people to kill cobras and the cobra population should decline. But people responded to the incentive rather than its underlying purpose. Some reportedly began breeding cobras specifically to kill them and collect the bounty. When authorities discovered what was happening and eliminated the program, breeders released their now-worthless snakes, leaving officials with more cobras than they had before.
People optimize for what you reward. The recreational cannabis market is experiencing its own version of this phenomenon. If customers demand genetics capable of producing exceptionally high THC percentages, breeding programs have an economic incentive to prioritize that trait.The industry gradually starts breeding its version of cobras.
We as cannabis breeders have access to an enormous collection of genetic traits. Plants can differ dramatically in morphology, flowering time, cannabinoid ratios, terpene production, environmental tolerance, disease resistance, yield, color, aroma, and many other characteristics. A healthy breeding ecosystem can preserve and recombine this diversity.But markets create selection pressure. When THC dominates purchasing decisions, breeders and producers may repeatedly select genetics based heavily on their ability to produce high THC results. That creates an important question for the industry:
What valuable characteristics are being discarded because they don't produce the biggest number on the package?
A cultivar with extraordinary terpene expression might disappear from commercial production because it only tests at 18% THC.
Another might offer excellent resistance to a particular environmental stress but struggle to compete commercially because it tests at 22%.
Meanwhile, a 30% cultivar may receive enormous attention simply because it satisfies the metric the marketplace has learned to reward.
Over time, that selection pressure narrows the genetic landscape.
The pressure does not stop at cultivation. Labs reporting lower numbers risk losing customers. Labs reporting higher numbers may attract them. The system intended to provide clarity through objectively measuring potency becomes muddied by the economic incentives surrounding potency. This does not mean laboratory testing is inherently unreliable. It means the economic structure surrounding testing deserves careful attention whenever the measurement directly affects the value of the product being measured.
The single greatest consequence of the THC arms race is a less interesting cannabis market. Consider wine. Imagine buying wine exclusively according to alcohol percentage. A 15% ABV bottle would automatically be considered superior to a 13% bottle. Wine consumers would immediately recognize the problem. Quality involves grape variety, terroir, acidity, aroma, aging, craftsmanship, vintage, and personal preference. Cannabis deserves similar nuance.
A lower-THC cultivar with an exceptional terpene profile may provide exactly the experience a particular consumer wants. Another consumer may prefer balanced cannabinoid ratios. Someone else may value flavor or aroma above maximum potency. Reducing all of these possibilities to a THC percentage turns a complex agricultural product into a one-dimensional horsepower competition.
Let me be clear, the solution is not to stop breeding high-THC cannabis. Potency is a legitimate characteristic, and consumers who prefer potent products should have access to them. The opportunity here is to make THC one characteristic rather than the sole metric of quality. Breeders can emphasize terpene diversity, minor cannabinoids, agronomic performance, distinctive sensory characteristics, and genetic preservation alongside potency. Producers can explain why they selected particular genetics instead of allowing laboratory percentages to tell the entire story.
Retailers can organize products around desired experiences, aroma profiles, genetics, and other meaningful characteristics rather than automatically positioning the highest-THC flower as the “premium” option. Consumers should be given enough information to discover that their favorite cultivar isn’t alwaysthe strongest one on the shelf.
While this may seem idealistic and naïve, I strongly believe our industry is still young enough to decide what "premium" cannabis actually means.